A real-world study to evaluate disease control based on symptoms severity in Greek patients with Benign Prostatic Hyperplasia (BPH) after 6 months of treatment under Fixed Dose Combination (FDC) with dutasteride/tamsulosin. The PROSPERITY I study

被引：0

作者：

Dimitriadis, G. ^{[1
]}

Kalaitzis, C. ^{[2
]}

Stamatiou, K. ^{[3
]}

Kotsiris, D. ^{[4
]}

Deirmentzoglou, S. ^{[5
]}

Loutriotis, A. ^{[6
]}

Papataxiarchou, K. ^{[6
]}

Tsioumas, G. ^{[6
]}

机构：

[1] Aristotle Univ Thessaloniki, Dept Urol 1, Sch Med, Thessaloniki, Greece

[2] Democritus Univ Thrace, Dept Urol, Alexandroupolis, Greece

[3] Tzaneio Gen Hosp, Dept Urol, Piraeus, Greece

[4] Dept Urol, Private Site, Athens, Greece

[5] Dept Urol, Private Site, Kavala, Greece

[6] ELPEN Pharmaceut Co Inc, Dept Med, Athens, Greece

来源：

关键词：

D O I：

暂无

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

A0808

引用

页码：S1809 / S1809

页数：1

共 1 条